T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited to the pancreas and size 2–4 cm T3 Tumor limited to the pancreas and size >4 cm or invading duodenum or bile duct T4 Tumor ...

Medically reviewed by Marla Anderson, MD Stomach cancer—or gastric cancer—occurs when cells in the lining of the stomach wall ...

Pathologist Michael Roehrl is part of a multidisciplinary team that evaluates and treats hundreds of people with neuroendocrine tumors every year. At Memorial Sloan Kettering Cancer Center, our ...

The stage of a neuroendocrine cancer tells you its size and whether it has spread ... Gastrinomas are rare neuroendocrine tumours (NETs) that develop in the pancreas or duodenum. They make large ...

We should not use these non age-standardised figures to compare survival with other groups, such as different cancer types, stages, or populations from other countries. The following statistics are ...

The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients ...

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...

Gastrointestinal neuroendocrine tumor. § Pancreatic neuroendocrine ... T3 Tumor limited to the pancreas and size >4 cm or invading duodenum or bile duct T4 Tumor invading other organs (stomach ...

With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer ...